Physician profile
Daniel A Wartinbee
NPI 1053586776
$3,025.21
in general payments reported to CMS, 2019-2025
23 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,040 · 2020: $15.69 · 2021: $110 · 2022: $77.44 · 2023: $186 · 2024: $219 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,963.04 | 2019 | |
| Kerecis Limited | $258.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sonex Health, INC. | $134.77 | 2024 | Sx-One Microknife |
| Smith+Nephew, INC. | $106.78 | 2019-2025 | Stravix, Aetos Shoulder System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Si-Bone, INC. | $66.87 | 2021-2024 | |
| Exsomed Corporation | $63.61 | 2021 | |
| Abbott Laboratories | $50.45 | 2019-2022 | |
| Organogenesis INC. | $45.50 | 2025 | Affinity |
| Fidia Pharma USA INC. | $41.56 | 2024-2025 | Hymovis, Hyalgan, Triluron |
| Amgen INC. | $37.54 | 2023-2025 | Krystexxa, Evenity, Prolia |
| Davol INC. | $33.09 | 2022-2023 | |
| Peerless Surgical INC. | $25.20 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.08 | 2024 | Iovera, Zilretta, Exparel |
| Biotissue Holdings INC. | $22.42 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.00 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $20.87 | 2025 | Exogen Ultrasound Bone Healing System |
| Ultragenyx Pharmaceutical INC. | $20.81 | 2023 | |
| Molnlycke Health Care US, LLC | $20.43 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Kuros Biosciences USA, INC | $18.32 | 2023 | |
| Curonix LLC | $14.15 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Horizon Therapeutics Plc | $13.55 | 2023 | Krystexxa |
| Medtronic USA, INC. | $11.49 | 2019 | |
| Zyla Life Sciences, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wartinbee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.